Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002].

Knisely, Anne; Huang, Yongmei; Li, Yeran; Prabhu, Vimalanand S; Wright, Jason D

Knisely, Anne; Huang, Yongmei; Li, Yeran; Prabhu, Vimalanand S; Wright, Jason D.

Afiliación

Knisely A; Columbia University College of Physicians and Surgeons, USA.
Huang Y; Herbert Irving Comprehensive Cancer Center, USA.
Li Y; Columbia University College of Physicians and Surgeons, USA.
Prabhu VS; Merck & Co., Inc., Kenilworth, NJ, USA.
Wright JD; Merck & Co., Inc., Kenilworth, NJ, USA.

Gynecol Oncol Rep ; 46: 101112, 2023 Apr.

Article en En | MEDLINE | ID: mdl-37082519

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos